End-of-life Decision-making in Patients With Sepsis-related Organ Failure (EIDECS)

August 8, 2017 updated by: Christiane Hartog, Center for Sepsis Control and Care, Germany

A Time-series Intervention Analysis of End-of-life Decision-making in Patients With Sepsis-related Organ Failure

The care of patients with sepsis-related organ failure on the intensive care unit (ICU) often includes end-of-life decision (EOL-D) and communication of such decisions to relatives. This increases the psychological burden for caregiver and relatives.

The investigators intend to assess the prevalence and impact of EOL-D on ICU care-givers and relatives ("before") and to use this data to develop and implement standard operating procedures (SOPs) for improved decision-making and communication of these decisions ("after").

The hypothesis is that an improved communication strategy will reduce symptoms of burnout in caregivers and symptoms of anxiety and depression in relatives.

Study Overview

Status

Completed

Conditions

Detailed Description

BACKGROUND About half of patients with sepsis related organ failure die on the ICU, frequently after end-of-life decisions (EOL-D), i.e. the decision to withdraw or withhold life-supporting therapies or forgo cardiopulmonary resuscitation. Lack of SOPs about how to communicate and share EOL-decisionmaking among staff and to communicate EOL-D to relatives may increase burnout and anxiety in staff as well as relatives. Also, there is uncertainty about the role of patients' advance directives in EOL-Decision-making.

HYPOTHESES 1. SOPs for interdisciplinary EOL-decisions will alleviate staff burnout; 2. A structured strategy to communicate EOL-decisions to relatives will lead to reduced anxiety and depression in relatives 3 months after the event.

AIMS 1. to develop SOPs for EOL-decision-making which improve timeliness of EOL-D and involvement of interdisciplinary care-givers. 2. to develop a strategy how to communicate these EOL-D to relatives including a structured procedure for participants, set-up, times and content. These aims may be adapted according to the findings of the observation period.

CONDUCT The study is designed as an interrupted time series analysis ("before/after study") located on the mixed, neurological and medical ICUs of the Jena University Hospital. It is composed of 3 observation periods separated by phases of data analysis and implementation of changes in behavioral practice. After the first phase of observation and data analysis, SOPs including an improved communication strategy with relatives will be developed on the basis of the collected data. SOPs will be developed and implemented on participating ICUs. In the following second observation period data will be collected to assess changed procedures and primary endpoints. A third round of data analysis, interpretation and observation will enable to further adapt SOPs and achieve sustainability ("post-implementation phase").

ESTIMATED ENROLLMENT Enrollment of 180 staff members (physicians and nursing staff) and 90 relatives during each study phase

Study Type

Interventional

Enrollment (Actual)

174

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Thuringia
      • Jena, Thuringia, Germany, 07747
        • Jena University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Staff:

Inclusion Criteria:

  • all physicians and nursing staff who treat patients with sepsis-related organ failure on participating ICUs who consent to participate

Exclusion Criteria:

  • Decline to participate

Relatives:

  • Relatives of patients with sepsis-related organ failure and EOL-D who consent to participate

Exclusion Criteria:

  • Decline to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: "Before"
No Intervention Observation of current practice
Other: "After"
SOPs for decision-making and communication Assessment of practice after implementation of SOPs
Development and implementation of SOPs for timely and interdisciplinary EOL-decisionmaking and a communication strategy with relatives which addresses participants, set-up, time-points, and content

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Symptoms of burnout by MBI score in ICU caregivers
Time Frame: once during observation period (1 year)
once during observation period (1 year)
Symptoms of post-traumatic stress disorder by IES and HADS scores in relatives at 90 days
Time Frame: once during observation period (1 year)
once during observation period (1 year)

Secondary Outcome Measures

Outcome Measure
Time Frame
Psychological symptoms by IES, HADS or MBI subscales in caregivers or relatives, respectively
Time Frame: once during the observation period (1 year)
once during the observation period (1 year)
Characteristics of patients with and without end-of-life decisions (EOL-D) including time periods (time until EOL-D, time between EOL-D until death or discharge) and 28-day and 90-day mortality rates
Time Frame: until death or discharge from the ICU
until death or discharge from the ICU
Prevalence and characteristics of EOL-D
Time Frame: until death or discharge from the ICU
until death or discharge from the ICU
Prevalence and characteristics of patients' advance directives
Time Frame: until death or discharge from the ICU
until death or discharge from the ICU
characteristics of EOL-D communication with relatives
Time Frame: ICU stay
ICU stay
Prevalence of request for "Ethik Konsil" (counseling by an external ethical review board)
Time Frame: until death or discharge from the ICU
until death or discharge from the ICU
direct costs of treatment of survivors and non-survivors
Time Frame: until death or discharge from the ICU
until death or discharge from the ICU

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christiane S Hartog, MD, Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2010

Primary Completion (Actual)

September 30, 2014

Study Completion (Actual)

September 30, 2014

Study Registration Dates

First Submitted

November 11, 2010

First Submitted That Met QC Criteria

November 23, 2010

First Posted (Estimate)

November 24, 2010

Study Record Updates

Last Update Posted (Actual)

August 9, 2017

Last Update Submitted That Met QC Criteria

August 8, 2017

Last Verified

August 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Severe Sepsis

Clinical Trials on SOPs for decision-making and communication

Subscribe